Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qidan Bimin Wan for seasonal allergic rhinitis (lung-spleen qi deficiency)
CTR20131942Phase 2Completed
- Sponsor
- Shanxi Yangwenshui Pharmaceutical
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Qidan Bimin Pill in seasonal allergic rhinitis (SAR), sponsored by Shanxi Yangwenshui Pharmaceutical. Started Jan 2014; status: completed.
02
Drugs
Qidan Bimin Pill
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on CTR20131942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131942.